Sunshine Biopharma Inc. Salary and Wage, Officer, Excluding Cost of Good and Service Sold
Sunshine Biopharma Inc. (SBFM) reported Salary and Wage, Officer, Excluding Cost of Good and Service Sold of $788.32 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OfficersCompensation · last filed 2025-11-13
- Sunshine Biopharma Inc. salary and wage, officer, excluding cost of good and service sold for the quarter ending 2025-09-30 was $788.32K, a 228.23% increase year-over-year.
- Sunshine Biopharma Inc. salary and wage, officer, excluding cost of good and service sold for the quarter ending 2025-06-30 was $524.50K, a 53.18% decline year-over-year.
- Sunshine Biopharma Inc. salary and wage, officer, excluding cost of good and service sold for the quarter ending 2025-03-31 was $269.50K, a 2.67% increase year-over-year.
- Sunshine Biopharma Inc. salary and wage, officer, excluding cost of good and service sold for the quarter ending 2024-09-30 was $240.18K, a 1.97% decline year-over-year.
| Period end | Salary and Wage, Officer, Excluding Cost of Good and Service Sold 3 month | Salary and Wage, Officer, Excluding Cost of Good and Service Sold 6 month | Salary and Wage, Officer, Excluding Cost of Good and Service Sold 9 month |
|---|---|---|---|
| 2025-09-30 | $788.32K 10-Q · filed 2025-11-13 | $1.31M derived: sum of 2 quarters · filed 2025-11-13 | $2.32M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $524.50K 10-Q · filed 2025-08-12 | $988.80K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $269.50K 10-Q · filed 2025-05-15 | ||
| 2024-09-30 | $240.18K 10-Q · filed 2025-11-13 | $1.36M derived: sum of 2 quarters · filed 2025-11-13 | $1.60M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $1.12M 10-Q · filed 2025-08-12 | $1.38M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $262.49K 10-Q · filed 2025-05-15 | ||
| 2023-09-30 | $245.00K 10-Q · filed 2024-11-05 | $470.00K derived: sum of 2 quarters · filed 2024-11-05 | $1.29M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $225.00K 10-Q/A · filed 2024-08-20 | $1.04M 10-Q/A · filed 2024-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |